Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Lactobacillus reuteri probiotic lozenge

An oral lozenge containing the DSM 17938 and ATCC PTA 5289 strains of the probiotic Gram-positive, naturally occurring bacterium Lactobacillus reuteri (L. reuteri), with potential antimicrobial, immunomodulatory and protective activities. Upon oral administration of L. reuteri probiotic lozenge, the Lactobacillus strain may modulate the composition of the oral biofilm, which may inhibit the colonization and recolonization of pathogens. It may also downregulate proinflammatory cytokines and reduce inflammation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:L. reuteri probiotic lozenge
US brand name:Prodentis
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search